Please login to the form below

Not currently logged in
Email:
Password:

HAS

This page shows the latest HAS news and features for those working in and with pharma, biotech and healthcare.

Sanofi sells European generics to Advent for $2.4bn

Sanofi sells European generics to Advent for $2.4bn

Private equity group Advent has agreed a 1.9bn ($2.4bn) deal to buy the European generics unit of French pharma company Sanofi. ... Sanofi has been looking to divest the Zentiva generics unit since 2016 as part of restructuring the business under chief

Latest news

  • P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit

    P&G has won the unit despite interest from other partners, including Nestle, Novartis and reportedly Mylan, which as recently as last week was said to be in advanced negotiations. ... consumer health joint venture last month, and Shire has sold its

  • Research Partnership adds to its team Research Partnership adds to its team

    London-based healthcare research and consulting firm Research Partnership has bolstered its leadership team with the addition of Dan Coffin.

  • Data integrity scuppers Fresenius deal with Akorn Data integrity scuppers Fresenius deal with Akorn

    The tie-up between the two companies - first announced a year ago - has looked vulnerable for several weeks. ... The company has indicated it is still interested in pursuing deals that will expand its presence in the US generics market.

  • Merck preps regulatory filings for much-needed antibiotic combo Merck preps regulatory filings for much-needed antibiotic combo

    Merck &Co has reported positive late-stage data for an antibiotic combination that could provide a new treatment option for serious and hard-to-treat Gram negative infections. ... The pivotal phase III trial showed that imipenem/cilastatin/relebactam was

  • New centre aims to Catapult UK into cell and gene therapy lead New centre aims to Catapult UK into cell and gene therapy lead

    There has been sustained investment in the translational space, [and] capital [to support businesses] has played a role in that. ... The Cell and Gene Catapult has been backed by more than £60m in government funding, with 160 of its own in-house experts.

More from news
Approximately 1 fully matching, plus 1,048 partially matching documents found.

Latest Intelligence

  • No incentive for a cure No incentive for a cure

    We won’t know for many years if the clinical and economic impact has been as significant as hoped. ... Broadly speaking, the industry has two choices; either incremental solutions, implemented in the confines.

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    And while the pipeline of new drugs has slowly dwindled, resistance has been on the rise. ... The Centre has announced its first three international co-development programmes with biotech companies since opening its labs in July 2017 and has more to come

  • Brexit Means Brexit Brexit Means Brexit

    Maintaining pharma’s voice. Pharma’s voice in the negotiations to date has been both impressive and effective. ... start. Pharma has already made huge progress in defining an outcome upon which both sides broadly agree.

  • What makes a meaningful brand? What makes a meaningful brand?

    Deliberate steps must be taken to ascribe meaning to a name that otherwise has no meaning, or to elicit an emotion from a seemingly ambiguous combination of colours and shapes. ... In essence, measuring customer-based brand equity once the brand has been

  • Beyond caring: learning from the unsung advocates in cancer care

    Beyond caring: learning from the unsung advocates in cancer care. Macmillan Cancer Support estimates that there are currently around 1.5 million carers caring for someone who has cancer in the ... What can we do for advocates? Increasing patient access

More from intelligence
Approximately 0 fully matching, plus 721 partially matching documents found.

Latest appointments

  • Sobi poaches Pfizer’s Fredrick Wetterlundh Sobi poaches Pfizer’s Fredrick Wetterlundh

    Swedish Orphan Biovitrum (Sobi) has appointed Fredrik Wetterlundh as head of human resources and will simultaneously be part of Sobi’s extended leadership team. ... Guido Oelkers, CEO and president of Sobi, said: “His experience from the

  • VCCP Health strengthens client service team VCCP Health strengthens client service team

    London, UK-based VCCP Health has bolstered its client service team with the addition of two new account handlers.

  • Smith & Nephew name new CEO Smith & Nephew name new CEO

    Global medical technology business Smith &Nephew has named Namal Nawana as its new chief executive officer. ... Nawana has joined Smith &Nephew from medical diagnostics company Alere, where he was also chief executive officer, and oversaw its $5.3bn

  • Targovax strengthens board of directors Targovax strengthens board of directors

    Clinical stage company Targovax has added to its board of directors with the appointment of Catherine Wheeler. ... She has had a long and distinguished career and has significant experience of bringing innovative oncology treatments to market that will

  • Dermavant strengthens executive team Dermavant strengthens executive team

    Dermavant Sciences, a biopharmaceutical company focused on delivering therapies for dermatologic conditions, has bolstered its executive team with the addition of four new hires. ... He has previously served as chief financial officer for Novan and chief

More from appointments
Approximately 0 fully matching, plus 1,000 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1,002 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics